Twist Bioscience holder reports 3.5% equity stake
William Blair Investment Management, LLC reported its beneficial ownership position in Twist Bioscience Corp common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
William Blair Investment Management, LLC reported its beneficial ownership position in Twist Bioscience Corp common stock. The firm reported beneficial ownership of 2,174,594 shares, representing 3.5% of the outstanding common stock. It has sole voting power over 1,975,454 shares and sole dispositive power over all 2,174,594 shares, with no shared voting or dispositive power. The filing indicates that the holder now owns 5 percent or less of the class of Twist Bioscience common stock. The reporting person is organized in Delaware and signed the report through its Chief Compliance Officer, Telmo Martins.
Key Figures
Key Terms
beneficially owned financial
sole voting power financial
sole dispositive power financial
percent of class financial
Schedule 13G/A regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who signed the Twist Bioscience (TWST) ownership report for William Blair Investment Management?
AI-generated analysis. How Rhea-AI works. Not financial advice.